Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Open-label, Multicenter Dose Escalation and Expansion Study of MT-5111 in Subjects With Previously Treated Advanced HER2-positive Solid Tumors

NCT04029922 is registered in ClinicalTrials.gov with Molecular Templates, Inc. as lead sponsor.

NCT NCT04029922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04029922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Open-label, Multicenter Dose Escalation and Expansion Study of MT-5111 in Subjects With Previously Treated Advanced HER2-positive Solid Tumors
Lead sponsor
Molecular Templates, Inc.
Phase
Phase 1
Overall status
Terminated
Start date
November 12, 2019
Completion date
April 27, 2023
Enrollment
50 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

her2-positive solid cancers